by Raymond Tel | Jan 22, 2019 | News
The first publication of 2019 is a fact, D. Nakladal from the University Medical Center Groningen (UMCG) investigated the effects of SUL-121 and its enantiomers SUL-150 and SUL-151 on vasorelaxation in porcine intrarenal arteries. Enantiomers are molecules with a same...
by Raymond Tel | Oct 24, 2018 | News
BIO-Europe is coming up in less than 2 weeks. Will you be there? If so, make sure that you schedule a meeting with our director Kees van der Graaf. We would be delighted to meet to explore ways that our SUL-compounds could help preventing acute kidney injury. Please...
by Raymond Tel | Oct 24, 2018 | News
Hibernation research leads to new medicines preventing Alzheimer, Diabetes Type 2 and acute kidney injury ‘Kidney tubule cells from hibernators have an increased resistance to oxidative stress compared to non-hibernators. Based on our research into hibernation, we...
by Raymond Tel | Oct 15, 2018 | News
Cooperation Sulfateq and UMCG recognizes with an Industrial Doctorates grant Last August 2018, the Netherlands Organization for Scientific Research (NWO) awarded an Industrial Doctorate grant to a collaborative project between Sulfateq B.V. and the group of Prof. dr....
by Raymond Tel | Oct 15, 2018 | Uncategorized
Samenwerking Sulfateq en UMCG erkent met een Industrial Doctorates subsidie Afgelopen augustus 2018 is door de Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) een Industrial Doctorate beurs toegekend aan een samenwerkingsproject tussen Sulfateq B.V. en...
